Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment

The discovery of the oncometabolite 2-hydroxyglutarate in isocitrate dehydrogenase 1–mutated (IDH1-mutated) tumor entities affirmed the role of metabolism in cancer. However, large databases with tissue metabolites that are modulated by IDH1 mutation remain an area of development. Here, we present a...

Descripción completa

Detalles Bibliográficos
Autores principales: Trautwein, Christoph, Zizmare, Laimdota, Mäurer, Irina, Bender, Benjamin, Bayer, Björn, Ernemann, Ulrike, Tatagiba, Marcos, Grau, Stefan J., Pichler, Bernd J., Skardelly, Marco, Tabatabai, Ghazaleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Resource and Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855807/
https://www.ncbi.nlm.nih.gov/pubmed/34941573
http://dx.doi.org/10.1172/jci.insight.153526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855807/
https://www.ncbi.nlm.nih.gov/pubmed/34941573
http://dx.doi.org/10.1172/jci.insight.153526

Ejemplares similares